Why the study?
A growing worldwide elderly population highlights the need to understand how aging promotes CVD in order to develop new strategies to confront this challenge.
Design
Review
Authors
Loading...
Supports heightened awareness of vascular aging in elderly CVD patients; leaves open targeted therapies pending dedicated trials.
This review highlights the mechanisms of cardiovascular aging and potential therapeutic targets to address the growing burden of CVD in the elderly.
Paneni et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: